BMJ Case Reports · 2017 · 11 citations · 19 references
MedicineOncologySurgeryGenitourinary OncologyNeoplasiaSurgical OncologyMalignant TumorsPenile CancerPenile SurgerySquamous Cell CarcinomaChemotherapy For Penile CancerImmunotherapy For Penile CancerLocalized LymphadenopathyPartial PenectomyRecurrent Disease SurgeryRecurrent Disease TherapySurgical Downstaging
Penile squamous cell carcinoma (pSCC) is a relatively rare disease in Western world but is a significant health problem in developing countries like India. We report here a case of successful multimodality management of recurrent pSCC with pelvic lymphadenopathy in a 56-year-old male patient with poorly controlled diabetes. The patient presented with ulceroproliferative growth over the residual penile stump clinically involving root of penis and with right pelvic lymphadenopathy. The patient had a history of partial penectomy done elsewhere 20 months ago. In view of the comorbidities, locally recurrent disease and presence of right Iliac lymphadenopathy, the patient was treated with nanosomal docetaxel lipid suspension (NDLS), cisplatin and 5-fluorouracil (TPF regimen) in the neoadjuvant setting followed by staged surgical resection. This is the first case report showing successful treatment of recurrent pSCC with NDLS-based TPF regimen in the neoadjuvant setting followed by staged surgery in a patient with poorly controlled diabetes.
19
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Medicine, Oncology, Chemotherapy +8
Robert I. Haddad, Anne O’Neill, Guilherme Rabinowits et al. · The Lancet Oncology · 2013 · 747 citations